WestEnd Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$632 Hold
3
﹤0.01% 327
2026
Q1
$663 Hold
3
﹤0.01% 286
2025
Q4
$761 Hold
3
﹤0.01% 272
2025
Q3
$742 Sell
3
-1
-25% -$239 ﹤0.01% 267
2025
Q2
$961 Hold
4
﹤0.01% 214
2025
Q1
$907 Buy
4
+3
+300% +$660 ﹤0.01% 218
2024
Q4
$206 Hold
1
﹤0.01% 254
2024
Q3
$243 Hold
1
﹤0.01% 268
2024
Q2
$220 Sell
1
-1
-50% -$217 ﹤0.01% 253
2024
Q1
$450 Hold
2
﹤0.01% 157
2023
Q4
$440 Buy
2
+1
+100% +$211 ﹤0.01% 167
2023
Q3
$219 Buy
+1
New +$226 ﹤0.01% 222
2023
Q1
Sell
-1
Closed -$193 237
2022
Q4
$185 Hold
1
﹤0.01% 232
2022
Q3
$0 Hold
1
﹤0.01% 303
2022
Q2
$206 Buy
+1
New +$225 ﹤0.01% 217
2022
Q1
Sell
-1
Closed -$232 212
2021
Q4
$243 Buy
+1
New +$228 ﹤0.01% 237
2021
Q3
Hold
0
245
2021
Q2
Hold
0
246

Other funds holding STE

WestEnd Advisors's STE Position: Q2 2026 in Review

WestEnd Advisors held its Steris (STE) position steady in Q2 2026 at 3 shares worth $632. The position accounts for ﹤0.01% of the portfolio, ranked #327.

WestEnd Advisors first reported a position in STE in Q4 2021 and has held it in 16 quarters since. The position peaked at $961 in Q2 2025. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • WestEnd Advisors held 3 shares of Steris worth $632 as of Q2 2026.
  • WestEnd Advisors left its Steris share count unchanged in Q2 2026.
  • Steris made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #327 holding.
  • WestEnd Advisors first reported a position in Steris in Q4 2021 and has held it in 16 quarters since.
  • WestEnd Advisors's Steris position peaked at $961 in Q2 2025.
  • 835 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.